CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
19 hedge funds and large institutions have $1.8M invested in Cyclo Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Holders
19
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
1 | +$120K | |
2 | +$18.9K | |
3 | +$2.37K | |
4 |
Bank of America
Charlotte,
North Carolina
|
+$618 |
5 |
UBS Group
Zurich,
Switzerland
|
+$320 |
Top Sellers
1 | -$61.4K | |
2 | -$31.3K | |
3 | -$18.2K | |
4 |
Renaissance Technologies
New York
|
-$17K |
5 |
PGAM
Princeton Global Asset Management
Princeton,
New Jersey
|
-$237 |